Paper7600567
Pharmacokinetics, tissue distribution, and in vivo antitumor effects of the antimelanoma immunotoxin ZME-gelonin.
Mujoo K and 3 others. Cancer Immunol Immunother, 1995. Cited by 25 papers, by iCite.
Cite this record
ConductScience Library. Pharmacokinetics, tissue distribution, and in vivo antitumor effects of the antimelanoma immunotoxin ZME-gelonin. Papers, record 7600567. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7600567
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Pharmacokinetics, tissue distribution, and in vivo antitumor effects of the antimelanoma immunotoxin ZME-gelonin.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents, Phytogenic | Major topic |
| Immunotoxins | Major topic |
| Melanoma | Major topic |
| Plant Proteins | Major topic |
| Protein Synthesis Inhibitors | Major topic |
| Animals | |
| Drug Screening Assays, Antitumor | |
| Female | |
| Injections, Intraperitoneal | |
| Mice | |
| Mice, Inbred BALB C | |
| Mice, Nude | |
| Neoplasm Transplantation | |
| Proteoglycans | |
| Ribosome Inactivating Proteins, Type 1 | |
| Tissue Distribution | |
| Transplantation, Heterologous |
Source PubMed
References28
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7189578 | Tumor localization of radio-labeled antibodies against carcinoembryonic antigen in patients with carcinoma: a critical evaluation. | N Engl J Med | 1980 | https://conductscience.org/library/papers/7189578 | PubMed |
| 2 | 6822875 | Imaging of melanoma with L-131-labeled monoclonal antibodies. | J Nucl Med | 1983 | https://conductscience.org/library/papers/6822875 | PubMed |
| 3 | 3698030 | Pharmacokinetics of radiolabeled monoclonal antibody B6.2 in patients with metastatic breast cancer. | Cancer Res | 1986 | https://conductscience.org/library/papers/3698030 | PubMed |
| 4 | 3821916 | Radioimmunoimaging in malignant melanoma patients with the use of indium-111-labeled antimelanoma monoclonal antibody (ZME-018) to high-molecular-weight antigen. | NCI Monogr | 1987 | https://conductscience.org/library/papers/3821916 | PubMed |
| 5 | 6218613 | Immunotoxins: a new approach to cancer therapy. | Science | 1983 | https://conductscience.org/library/papers/6218613 | PubMed |
| 6 | 3930572 | Characterization of immunotoxins active against ovarian cancer cell lines. | J Clin Invest | 1985 | https://conductscience.org/library/papers/3930572 | PubMed |
| 7 | 2253201 | Pharmacokinetics in the rat of a panel of immunotoxins made with abrin A chain, ricin A chain, gelonin, and momordin. | Cancer Res | 1990 | https://conductscience.org/library/papers/2253201 | PubMed |
| 8 | 7391060 | Gelonin, a new inhibitor of protein synthesis, nontoxic to intact cells. Isolation, characterization, and preparation of cytotoxic complexes with concanavalin A. | J Biol Chem | 1980 | https://conductscience.org/library/papers/7391060 | PubMed |
| 9 | 3499221 | New coupling agents for the synthesis of immunotoxins containing a hindered disulfide bond with improved stability in vivo. | Cancer Res | 1987 | https://conductscience.org/library/papers/3499221 | PubMed |
| 10 | 3495329 | Immunotoxins to a human melanoma-associated antigen: comparison of gelonin with ricin and other A chain conjugates. | Cancer Res | 1987 | https://conductscience.org/library/papers/3495329 | PubMed |
| 11 | 4044586 | Purified immunotoxins that are reactive with human lymphoid cells. Monoclonal antibodies conjugated to the ribosome-inactivating proteins gelonin and the pokeweed antiviral proteins. | J Biol Chem | 1985 | https://conductscience.org/library/papers/4044586 | PubMed |
| 12 | 7033148 | Distribution and molecular characterization of a cell-surface and a cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodies. | Int J Cancer | 1981 | https://conductscience.org/library/papers/7033148 | PubMed |
| 13 | 2738650 | Development of a stable radioiodinating reagent to label monoclonal antibodies for radiotherapy of cancer. | J Nucl Med | 1989 | https://conductscience.org/library/papers/2738650 | PubMed |
| 14 | 3492271 | Effect of chemical deglycosylation of ricin A chain on the in vivo fate and cytotoxic activity of an immunotoxin composed of ricin A chain and anti-Thy 1.1 antibody. | Cancer Res | 1987 | https://conductscience.org/library/papers/3492271 | PubMed |
| 15 | 2899092 | In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates. IV. Cytotoxic effect of an anti-T11-gelonin immunotoxin. | J Clin Invest | 1988 | https://conductscience.org/library/papers/2899092 | PubMed |
| 16 | 7375942 | Clinical radioimmunodetection of cancer with radioactive antibodies to human chorionic gonadotropin. | Science | 1980 | https://conductscience.org/library/papers/7375942 | PubMed |
| 17 | 2461993 | Ricin A-chain containing immunotoxins directed against different epitopes on the CD2 molecule differ in their ability to kill normal and malignant T cells. | J Immunol | 1988 | https://conductscience.org/library/papers/2461993 | PubMed |
| 18 | 3502450 | Effect of linkage variation on pharmacokinetics of ricin A chain-antibody conjugates in normal rats. | Anticancer Drug Des | 1986 | https://conductscience.org/library/papers/3502450 | PubMed |
| 19 | 3317828 | Redesigning nature's poisons to create anti-tumor reagents. | Science | 1987 | https://conductscience.org/library/papers/3317828 | PubMed |
| 20 | 3536124 | Immunotoxins. | Cell | 1986 | https://conductscience.org/library/papers/3536124 | PubMed |
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35338415 | Targeted Delivery of Endosomal Escape Peptides to Enhance Immunotoxin Potency and Anti-cancer Efficacy. | AAPS J | 2022 | https://conductscience.org/library/papers/35338415 | PubMed |
| 31293965 | The Melding of Drug Screening Platforms for Melanoma. | Front Oncol | 2019 | https://conductscience.org/library/papers/31293965 | PubMed |
| 26636901 | Key factors influencing ADME properties of therapeutic proteins: A need for ADME characterization in drug discovery and development. | MAbs | 2016 | https://conductscience.org/library/papers/26636901 | PubMed |
| 25341935 | Immunotoxins constructed with ribosome-inactivating proteins and their enhancers: a lethal cocktail with tumor specific efficacy. | Curr Pharm Des | 2014 | https://conductscience.org/library/papers/25341935 | PubMed |
| 23973813 | Chemically and biologically synthesized CPP-modified gelonin for enhanced anti-tumor activity. | J Control Release | 2013 | https://conductscience.org/library/papers/23973813 | PubMed |
| 22190999 | Cell Internalization Studies of Gadofullerene-(ZME-018) Immunoconjugates into A375m Melanoma Cells. | Transl Oncol | 2011 | https://conductscience.org/library/papers/22190999 | PubMed |
| 16790087 | The antimelanoma immunocytokine scFvMEL/TNF shows reduced toxicity and potent antitumor activity against human tumor xenografts. | Neoplasia | 2006 | https://conductscience.org/library/papers/16790087 | PubMed |
| 16611405 | Targeted apoptosis activation with GrB/scFvMEL modulates melanoma growth, metastatic spread, chemosensitivity, and radiosensitivity. | Neoplasia | 2006 | https://conductscience.org/library/papers/16611405 | PubMed |
| 14649886 | Targeting the over-expressed urokinase-type plasminogen activator receptor on glioblastoma multiforme. | J Neurooncol | 2003 | https://conductscience.org/library/papers/14649886 | PubMed |
| 14627129 | Preclinical evaluation of anti-CD86 immunotoxin in rhesus monkeys: analysis of systemic toxicity, pharmacokinetics, and effect on primary T-cell responses. | Cancer Immunol Immunother | 2003 | https://conductscience.org/library/papers/14627129 | PubMed |
| 12952291 | Immunotoxin therapy for CNS tumor. | J Neurooncol | 2003 | https://conductscience.org/library/papers/12952291 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7600567
GET https://conductscience.org/api/papers/v1/7600567/references?page=2